Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation

Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis

Landin Boring, Jennifa Gosling, Michael D. Cleary et al. · Nature · 1998 · 2K citations

Life Sciences, Immunology, Pathology +14

Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice

Long Gu, Yoshikatsu Okada, Steven K. Clinton et al. · Molecular Cell · 1998 · 1.6K citations · Full text

Life Sciences, Immunology, Molecular Biology +12

Efficacy and Safety of Edifoligide, an E2F Transcription Factor Decoy, for Prevention of Vein Graft Failure Following Coronary Artery Bypass Graft Surgery

JAMA · 2005 · 659 citations

Medicine, Pharmacotherapy, Surgery +13

Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery

Michael S. Conte, Dennis F. Bandyk, Alexander W. Clowes et al. · Journal of Vascular Surgery · 2006 · 640 citations · Full text

Medicine, Orthopedic Surgery, Surgery +12

Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial

Michael J. Mann, Anthony D. Whittemore, Magruder C. Donaldson et al. · The Lancet · 1999 · 402 citations

Medicine, Biotechnology, Surgery +16